News & Press
IBSA Group and Granata Bio announces first patient screened in pivotal PROGRESS clinical trial of Progesterone-IBSA
IBSA Group and Granata Bio announces first patient screened in pivotal PROGRESS clinical trial of Progesterone-IBSA
Granata Bio is Partnering with RESOLVE: The National Infertility Association
Granata Bio is partnering with RESOLVE: The National Infertility Association, to better understand clinical trials from the patients’ perspective
Granata Bio CEO, Evan Sussman to Moderate Panel on Innovation in Reproductive Health
Granata Bio is excited to have Dr. Denny Sakkas from Boston IVF, Dr. Lynn Westphal from Kindbody and Dr. Ken Carson from Tempus Labs, Inc. participate in a panel discussion on Innovation in Drug Discovery, R&D & Reproductive Health, moderated by our CEO, Evan Sussman. At this year’s Reproductive Health Innovative Summit on February 15-16 in Boston, MA.
Partnership with Women’s Health Innovation Series
Granata Bio announces partnership with the Women’s Health Innovation Series: Reproductive Health Innovation Summit (Feb 15-16, 2022)
Biggest learns over the last 12 months: x4 Life Sciences Interview with CEO at Granata Bio
Granata Bio CEO, Evan Sussman was interviewed by X4 Life Science about his experience cofounding Granata Bio and his key learnings over the past year.
Granata Bio sponsors RESOLVE Kitchen Table Conversations, The Many Perspectives of Living Without Children
Granata Bio sponsors RESOLVE Kitchen Table Conversations, The Many Perspectives of Living Without Children
Granata Bio will be participating in two panels this year’s virtual Fertility Innovation Summit taking place on April 20, 2021
Granata Bio will be participating in two panels this year’s virtual Fertility Innovation Summit taking place on April 20, 2021
Yale School of Management Catching Up with Alumni: The Founders of Granata Bio
A new series in which we reach out to alumni of the MBA for Executives program to learn more about their time at Yale SOM and how it’s impacted their lives since graduation. We checked in with three founders of Granata Bio, a fertility company that aims to bring new medications in the field to the United States.